Mavacamten real-world experience: insights from the Dutch HCM Network.

Back

ESC Professional Premium Access

Mavacamten real-world experience: insights from the Dutch HCM Network.

Session: Myocardial disease and valvular heart disease: miscellany

Topic: Pharmacotherapy

Speaker: Doctor P. Zwetsloot (Rotterdam, NL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Peter-Paul Zwetsloot

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

1 follower

6 more presentations in this session

Radiofrequency septal ablation as a therapeutic option in refractory obstructive hypertrophic cardiomyopathy to myectomy: a case series

Speaker: Doctor F. De Brito Fortuna (Sao Paulo, BR)

Impact of sodium-glucose co-transporter inhibitors in mortality and decongestion in cardiac amyloidosis: A systematic review and meta-analysis

Speaker: Mrs C. christiane (Sao Paulo, BR)

Temporal and demographic disparities in cardiogenic shock mortality among patients with ischemic cardiomyopathy in the United States, 1999-2020

Speaker: Doctor A. Zafar (Wigan, GB)

Cardiac mechanics in primary mitral regurgitation: effect of exercise in cardiac strain and hemodynamic parameters

Speaker: Doctor I. Dimitroglou (Athens, GR)

The prognostic value of small psoas muscle area in patients undergoing mitral edge-to-edge repair

Speaker: Doctor R. Shigeno (Okayama, JP)

Access the full session

Myocardial disease and valvular heart disease: miscellany

Speakers: Doctor P. Zwetsloot, Doctor F. De Brito Fortuna, Mrs C. christiane, Doctor A. Zafar, Doctor I. Dimitroglou...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources